HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

Asia Pacific Microbial Transglutaminase Market Size & Outlook, 2025-2033


Asia Pacific Microbial Transglutaminase Market Insights

  • As per Reed Intelligence insights, Asia Pacific’s Microbial Transglutaminase Market was valued at USD 39.31 Million in 2024 and is anticipated to expand to USD 91.06 Million by 2033.
  • From 2026 to 2033, the market is anticipated to expand at a CAGR of 9.93%.
  • Within By Source, Streptomyces Mobaraense accounted for the largest market size in 2024.
  • During the forecast period, Others is anticipated to remain the highest-growth segment within the By Source category.

Other Key Findings


  • The global Microbial Transglutaminase Market size saw Asia Pacific holding a share of 28.8% in 2024.
  • United States is forecasted to account for the leading share of the global market by 2033.
  • In Asia Pacific, China is forecasted to be the fastest-expanding market, projected to reach USD 36.3 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 39.31 Million
Market Size In 2033 USD 91.06 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.93% (2025-2033)
Segmnetation Covered
Asia Pacific
  1. China
  2. India
  3. Japan
  4. Korea
  5. Taiwan
  6. Australia
  7. Singapore
  8. South East Asia
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports